Agios Pharmaceuticals AGIO Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agios Pharmaceuticals's net income?
- Agios Pharmaceuticals (AGIO) reported net income of -$99.11M in Q1 2026.
- How has Agios Pharmaceuticals's net income changed year-over-year?
- Agios Pharmaceuticals's net income decreased by 11.0% year-over-year, from -$89.29M to -$99.11M.
- What is the long-term trend for Agios Pharmaceuticals's net income?
- Over 2 years (2021 to 2025), Agios Pharmaceuticals's net income has grown at a -50.7% compound annual growth rate (CAGR), from $1.7B to -$412.78M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.